Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

66.7%

2 terminated/withdrawn out of 3 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

300%

3 of 1 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 4
1(33.3%)
3Total
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT00847002Not ApplicableTerminated

Flexitouch Treatment for Venous Ulcers

Role: lead

NCT00880022Not ApplicableCompleted

Home-based Compression Therapy for Arm and Truncal Lymphedema in Breast Cancer

Role: collaborator

NCT00534937Phase 4Terminated

Flexitouch Compression System for Venous Stasis Ulcer

Role: collaborator

All 3 trials loaded